Modern combined modality management of Hodgkin's disease.
The combination of chemotherapy and irradiation in the management of patients with Hodgkin's disease is being reported with increased frequency. In some situations, higher cure rates have been achieved with combined modality. In other situations, a reduction or modification of one or both modalities has reduced the acute toxicity (and later morbidity) of successful therapy.
Rosenberg
S A
SA
Division of Oncology, Stanford Medical Center, CA 94305.
D003131:Combined Modality Therapy; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans